SSA
MBIO icon

Schonfeld Strategic Advisors’s Mustang Bio MBIO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19
Closed -$5.77K – 2407
2022
Q4 		$5.77K Sell
19
-4
-17% -$1.37K ﹤0.01% 2364
2022
Q3 		$8K Buy
+23
New +$10.7K ﹤0.01% 2738
2020
Q4 		– Sell
-140
Closed -$331K – 1743
2020
Q3 		$331K Sell
140
-378
-73% -$932K 0.01% 1057
2020
Q2 		$1.24M Buy
+518
New +$1.21M 0.03% 549
2019
Q4 		– Sell
-201
Closed -$492K – 1404
2019
Q3 		$492K Sell
201
-34
-14% -$93K 0.01% 652
2019
Q2 		$650K Buy
+235
New +$671K 0.02% 565

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's MBIO Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of Mustang Bio (MBIO) in Q1 2023, closing a stake of 19 shares — an estimated $5.77K sold.

Schonfeld Strategic Advisors first reported a position in MBIO in Q2 2019 and held it in 6 quarters. The position peaked at $1.24M in Q2 2020. 48 funds tracked by Wall St. Rank hold MBIO as of Q1 2023.

  • Schonfeld Strategic Advisors reported no remaining Mustang Bio position as of Q1 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 19 Mustang Bio shares in Q1 2023, an estimated $5.77K.
  • Schonfeld Strategic Advisors first reported a position in Mustang Bio in Q2 2019 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's Mustang Bio position peaked at $1.24M in Q2 2020.
  • 48 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.